tiprankstipranks
Trending News
More News >
Extendicare (TSE:EXE)
TSX:EXE
Canadian Market

Extendicare (EXE) Technical Analysis

Compare
196 Followers

Summary of all the Indicators

Overall Consensus
Buy
10Bullish
6Neutral
6Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Extendicare’s (EXE) Moving Averages Convergence Divergence (MACD) indicator is 0.32, suggesting Extendicare is a Buy.
Extendicare’s (EXE) 20-Day exponential moving average is 14.15, while Extendicare’s (EXE) share price is C$14.31, making it a Buy.
Extendicare’s (EXE) 50-Day exponential moving average is 13.46, while Extendicare’s (EXE) share price is C$14.31, making it a Buy.

Extendicare (EXE) Pivot Points

May 24, 2025, 09:30 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
13.64
13.84
14.04
14.24
14.45
14.65
14.85
Fibonacci
13.84
13.99
14.09
14.24
14.40
14.49
14.65
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Extendicare (EXE) Moving Averages

May 24, 2025, 09:30 PM
Period
Simple
Exponential
MA5
14.48Sell
14.39Sell
MA10
14.44Sell
14.36Sell
MA20
14.20Buy
14.15Buy
MA50
13.47Buy
13.46Buy
MA100
12.22Buy
12.47Buy
MA200
10.71Buy
10.86Buy
Extendicare’s (EXE) 10-Day exponential moving average is 14.36, while Extendicare’s (EXE) share price is C$14.31, making it a Sell.
Extendicare’s (EXE) 100-Day exponential moving average is 12.47, while Extendicare’s (EXE) share price is C$14.31, making it a Buy.
Extendicare’s (EXE) stock price is C$14.31 and Extendicare’s (EXE) 50-day simple moving average is 13.47, creating a Buy signal.
Extendicare’s (EXE) stock price is C$14.31 and Extendicare’s (EXE) 100-day simple moving average is 12.22, creating a Buy signal.
Extendicare’s (EXE) stock price is C$14.31 and Extendicare’s (EXE) 200-day simple moving average is 10.71, creating a Buy signal.

Extendicare (EXE) Technical Indicators

May 24, 2025, 09:30 PM
Name
Value
Implied Action
RSI (14)
56.82
Neutral
STOCH (9,6)
42.77
Neutral
STOCHRSI (14)
45.56
Neutral
MACD (12,26)
0.32
Buy
ADX (14)
20.57
Neutral
Williams %R
-55.03
Buy
CCI (14)
17.13
Neutral
ATR (14)
0.38
-
Ultimate Oscillator
49.09
Neutral
ROC
-1.31
Sell
Extendicare’s (EXE) Relative Strength Index (RSI) is 56.82, creating a Neutral signal.
Extendicare’s (EXE) Trend Strength Indicator (ADX) is 20.57, creating a Neutral signal.
Extendicare’s (EXE) Commodity Channel Index (CCI) is 17.13, creating a Neutral signal.
Extendicare’s (EXE) Price Rate of Change (ROC) is -1.31, creating a Sell signal.

FAQ

Is EXE a Buy, Hold, or Sell?
Based on EXE’s technical indicators, EXE is a Buy.
    What is EXE’s RSI (14)?
    EXE’s RSI (14) is 56.82, which suggests EXE is a Neutral.
      What is EXE’s MACD?
      EXE’s MACD is 0.32, which suggests EXE is a Buy.
        What is EXE’s 5-day moving average?
        EXE’s 5-day moving average is 14.48, which suggests EXE is a Sell.
          What is EXE’s 20-day moving average?
          EXE 20-day moving average is 14.20, which suggests EXE is a Buy.
            What is EXE’s 50-day moving average?
            EXE’s 50-day moving average is 13.47, which suggests EXE is a Buy.
              What is EXE’s 200-day moving average?
              EXE’s 200-day moving average is 10.71, which suggests EXE is a Buy.
                What is EXE’s Williams % R (14)?
                EXE’s Williams % R (14) is -55.03, which suggests EXE is a Buy.
                  What is EXE’s CCI (14)?
                  EXE’s CCI (14) is 17.13, which suggests EXE is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis